The EKG in the patient treated with encainide, flecainide and propafenone: Difference between revisions
Jump to navigation
Jump to search
m (Protected "The EKG in the patient treated with encainide, flecainide and propafenone" ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +)) |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
Line 21: | Line 21: | ||
{{Electrocardiography}} | {{Electrocardiography}} | ||
[[Category:Electrophysiology]] | [[Category:Electrophysiology]] |
Latest revision as of 15:27, 6 September 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Electrocardiographic Findings
- Prolong the PR and the QRS
- Propafenone may also slow the sinus rate due to its β-blocking effects
Additional resources
- ECGpedia: Course for interpretation of ECG
- The whole ECG - A basic ECG primer
- 12-lead ECG library
- Simulation tool to demonstrate and study the relation between the electric activity of the heart and the ECG
- ECG information from Children's Hospital Heart Center, Seattle
- ECG Challenge from the ACC D2B Initiative
- National Heart, Lung, and Blood Institute, Diseases and Conditions Index
- A history of electrocardiography
- EKG Interpretations in infants and children